4 1 edgar.txt FORM 4 - 12/31/2001 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP ( ) Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instructions 1(b). 1. Name and Address of Reporting Person Hoover, Michael K c/o 2555 Davie Road, Suite 110 Fort Lauderdale, FL 33317 USA 2. Issuer Name and Ticker or Trading Symbol ProxyMed, Inc. PILL 3. IRS or Social Security Number of Reporting Person (Voluntary) 4. Statement for Month/Year 12/31/2001 5. If Amendment, Date of Original (Month/Year) 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) (X) Director ( ) 10% Owner (X) Officer (give title below) ( ) Other (specify below) Chairman and Chief Executive Officer 7. Individual or Joint/Group Filing (Check Applicable Line) (X) Form filed by One Reporting Person ( ) Form filed by More than One Reporting Person

Explanation of Responses: * Issued as a result of Reporting Person's participation in a Conversion Offering dated 12/12/01 applicable to holders of Series C 7% Convertible Preferred Stock. A total of 9,962 of these shares are restricted securities unless or until such time as the shares are registered. **Adjusted to reflect the 1-for-15 reverse stock split on 8/21/01. Amount of Securities Beneficially Owned at End of Month also includes Series C dividend shares acquired since last report. SIGNATURE OF REPORTING PERSON Michael K. Hoover DATE January 3, 2002

HOOVER MICHAEL K 4